US Patent 8293239 Methods of treating chronic pain

Patent 8293239 was granted and assigned to Pfizer Limited on October, 2012 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors Activity

Is a

Patent

Patent attributes

Current Assignee

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

8293239

Patent Inventor Names

Joerg Zeller0

Laura Corradini0

David Louis Shelton0

Ian Machin0

Kristian Todd Poulsen0

Date of Patent

October 23, 2012

Patent Application Number

12920621

Date Filed

March 3, 2009

Patent Citations Received

‌

US Patent 12122821 Regulation of glucose metabolism using anti-CGRP antibodies

Patent Primary Examiner

‌

Christine J. Saoud

No article content yet.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 8293239 Methods of treating chronic pain

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Access by API